CEO and Founder of Kalyagen
Endogenous Stem Cell Mobilization (ESCM) emerges to the treatment of a variety of degenerative conditions. Simply stimulating the mobilization of stem cells from the bone marrow, therefore increasing the number of circulating stem cells available to migrate in various tissues, has been shown to be a promising therapeutic approach tapping into the potential of adult stem cells. Christian Drapeau will introduce at the 2024 Longevity Med Summit the potential and therapeutic application of the Endogenous stem cell mobilization.
Christian Drapeau
Sign up to receive the Longevity Med Summit
updates and more
Youtube